The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Enteric Disease Testing and Therapeutic-Global Market Insights and Sales Trends 2024
Synopsis
Enteric diseases are the infections caused by ingestion of contaminated food or water. These infections are commonly caused by bacteria and viruses. Poor maintenance of hygiene and sanitation, particularly due to rising population and urbanization is increasing the prevalence of enteric diseases.
The global Enteric Disease Testing and Therapeutic market size is expected to reach US$ 3330.2 million by 2029, growing at a CAGR of 1.4% from 2023 to 2029. The market is mainly driven by the significant applications of Enteric Disease Testing and Therapeutic in various end use industries. The expanding demands from the Hospital, Specialty Clinic and Others,, are propelling Enteric Disease Testing and Therapeutic market. Bacterial Disease, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Viral Disease segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Enteric Disease Testing and Therapeutic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Enteric Disease Testing and Therapeutic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Enteric Disease Testing and Therapeutic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Enteric Disease Testing and Therapeutic sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Enteric Disease Testing and Therapeutic covered in this report include Abbott, GlaxoSmithKline, Becton Dickinson, bioMérieux, Sanofi, Bayer Pharma, Bio-Rad, Quest Diagnostics and Trinity Biotech, etc.
The global Enteric Disease Testing and Therapeutic market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
GlaxoSmithKline
Becton Dickinson
bioMérieux
Sanofi
Bayer Pharma
Bio-Rad
Quest Diagnostics
Trinity Biotech
Global Enteric Disease Testing and Therapeutic market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Enteric Disease Testing and Therapeutic market, Segment by Type:
Bacterial Disease
Viral Disease
Parasitic Disease
Global Enteric Disease Testing and Therapeutic market, by Application
Hospital
Specialty Clinic
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Enteric Disease Testing and Therapeutic companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Enteric diseases are the infections caused by ingestion of contaminated food or water. These infections are commonly caused by bacteria and viruses. Poor maintenance of hygiene and sanitation, particularly due to rising population and urbanization is increasing the prevalence of enteric diseases.
The global Enteric Disease Testing and Therapeutic market size is expected to reach US$ 3330.2 million by 2029, growing at a CAGR of 1.4% from 2023 to 2029. The market is mainly driven by the significant applications of Enteric Disease Testing and Therapeutic in various end use industries. The expanding demands from the Hospital, Specialty Clinic and Others,, are propelling Enteric Disease Testing and Therapeutic market. Bacterial Disease, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Viral Disease segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Enteric Disease Testing and Therapeutic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Enteric Disease Testing and Therapeutic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Enteric Disease Testing and Therapeutic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Enteric Disease Testing and Therapeutic sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Enteric Disease Testing and Therapeutic covered in this report include Abbott, GlaxoSmithKline, Becton Dickinson, bioMérieux, Sanofi, Bayer Pharma, Bio-Rad, Quest Diagnostics and Trinity Biotech, etc.
The global Enteric Disease Testing and Therapeutic market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
GlaxoSmithKline
Becton Dickinson
bioMérieux
Sanofi
Bayer Pharma
Bio-Rad
Quest Diagnostics
Trinity Biotech
Global Enteric Disease Testing and Therapeutic market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Enteric Disease Testing and Therapeutic market, Segment by Type:
Bacterial Disease
Viral Disease
Parasitic Disease
Global Enteric Disease Testing and Therapeutic market, by Application
Hospital
Specialty Clinic
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Enteric Disease Testing and Therapeutic companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Enteric Disease Testing and Therapeutic
1.1 Enteric Disease Testing and Therapeutic Market Overview
1.1.1 Enteric Disease Testing and Therapeutic Product Scope
1.1.2 Enteric Disease Testing and Therapeutic Market Status and Outlook
1.2 Global Enteric Disease Testing and Therapeutic Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Enteric Disease Testing and Therapeutic Market Size by Region (2018-2029)
1.4 Global Enteric Disease Testing and Therapeutic Historic Market Size by Region (2018-2023)
1.5 Global Enteric Disease Testing and Therapeutic Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Enteric Disease Testing and Therapeutic Market Size (2018-2029)
1.6.1 North America Enteric Disease Testing and Therapeutic Market Size (2018-2029)
1.6.2 Europe Enteric Disease Testing and Therapeutic Market Size (2018-2029)
1.6.3 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size (2018-2029)
1.6.4 Latin America Enteric Disease Testing and Therapeutic Market Size (2018-2029)
1.6.5 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size (2018-2029)
2 Enteric Disease Testing and Therapeutic Market by Type
2.1 Introduction
2.1.1 Bacterial Disease
2.1.2 Viral Disease
2.1.3 Parasitic Disease
2.2 Global Enteric Disease Testing and Therapeutic Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Enteric Disease Testing and Therapeutic Historic Market Size by Type (2018-2023)
2.2.2 Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Enteric Disease Testing and Therapeutic Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Enteric Disease Testing and Therapeutic Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Enteric Disease Testing and Therapeutic Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Enteric Disease Testing and Therapeutic Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Enteric Disease Testing and Therapeutic Revenue Breakdown by Type (2018-2029)
3 Enteric Disease Testing and Therapeutic Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Specialty Clinic
3.1.3 Others
3.2 Global Enteric Disease Testing and Therapeutic Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Enteric Disease Testing and Therapeutic Historic Market Size by Application (2018-2023)
3.2.2 Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Enteric Disease Testing and Therapeutic Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Enteric Disease Testing and Therapeutic Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Enteric Disease Testing and Therapeutic Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Enteric Disease Testing and Therapeutic Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Enteric Disease Testing and Therapeutic Revenue Breakdown by Application (2018-2029)
4 Enteric Disease Testing and Therapeutic Competition Analysis by Players
4.1 Global Enteric Disease Testing and Therapeutic Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Enteric Disease Testing and Therapeutic as of 2022)
4.3 Date of Key Players Enter into Enteric Disease Testing and Therapeutic Market
4.4 Global Top Players Enteric Disease Testing and Therapeutic Headquarters and Area Served
4.5 Key Players Enteric Disease Testing and Therapeutic Product Solution and Service
4.6 Competitive Status
4.6.1 Enteric Disease Testing and Therapeutic Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott Enteric Disease Testing and Therapeutic Products, Services and Solutions
5.1.4 Abbott Enteric Disease Testing and Therapeutic Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Recent Developments
5.2 GlaxoSmithKline
5.2.1 GlaxoSmithKline Profile
5.2.2 GlaxoSmithKline Main Business
5.2.3 GlaxoSmithKline Enteric Disease Testing and Therapeutic Products, Services and Solutions
5.2.4 GlaxoSmithKline Enteric Disease Testing and Therapeutic Revenue (US$ Million) & (2018-2023)
5.2.5 GlaxoSmithKline Recent Developments
5.3 Becton Dickinson
5.3.1 Becton Dickinson Profile
5.3.2 Becton Dickinson Main Business
5.3.3 Becton Dickinson Enteric Disease Testing and Therapeutic Products, Services and Solutions
5.3.4 Becton Dickinson Enteric Disease Testing and Therapeutic Revenue (US$ Million) & (2018-2023)
5.3.5 bioMérieux Recent Developments
5.4 bioMérieux
5.4.1 bioMérieux Profile
5.4.2 bioMérieux Main Business
5.4.3 bioMérieux Enteric Disease Testing and Therapeutic Products, Services and Solutions
5.4.4 bioMérieux Enteric Disease Testing and Therapeutic Revenue (US$ Million) & (2018-2023)
5.4.5 bioMérieux Recent Developments
5.5 Sanofi
5.5.1 Sanofi Profile
5.5.2 Sanofi Main Business
5.5.3 Sanofi Enteric Disease Testing and Therapeutic Products, Services and Solutions
5.5.4 Sanofi Enteric Disease Testing and Therapeutic Revenue (US$ Million) & (2018-2023)
5.5.5 Sanofi Recent Developments
5.6 Bayer Pharma
5.6.1 Bayer Pharma Profile
5.6.2 Bayer Pharma Main Business
5.6.3 Bayer Pharma Enteric Disease Testing and Therapeutic Products, Services and Solutions
5.6.4 Bayer Pharma Enteric Disease Testing and Therapeutic Revenue (US$ Million) & (2018-2023)
5.6.5 Bayer Pharma Recent Developments
5.7 Bio-Rad
5.7.1 Bio-Rad Profile
5.7.2 Bio-Rad Main Business
5.7.3 Bio-Rad Enteric Disease Testing and Therapeutic Products, Services and Solutions
5.7.4 Bio-Rad Enteric Disease Testing and Therapeutic Revenue (US$ Million) & (2018-2023)
5.7.5 Bio-Rad Recent Developments
5.8 Quest Diagnostics
5.8.1 Quest Diagnostics Profile
5.8.2 Quest Diagnostics Main Business
5.8.3 Quest Diagnostics Enteric Disease Testing and Therapeutic Products, Services and Solutions
5.8.4 Quest Diagnostics Enteric Disease Testing and Therapeutic Revenue (US$ Million) & (2018-2023)
5.8.5 Quest Diagnostics Recent Developments
5.9 Trinity Biotech
5.9.1 Trinity Biotech Profile
5.9.2 Trinity Biotech Main Business
5.9.3 Trinity Biotech Enteric Disease Testing and Therapeutic Products, Services and Solutions
5.9.4 Trinity Biotech Enteric Disease Testing and Therapeutic Revenue (US$ Million) & (2018-2023)
5.9.5 Trinity Biotech Recent Developments
6 North America
6.1 North America Enteric Disease Testing and Therapeutic Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Enteric Disease Testing and Therapeutic Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Enteric Disease Testing and Therapeutic Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Enteric Disease Testing and Therapeutic Market Dynamics
11.1 Enteric Disease Testing and Therapeutic Industry Trends
11.2 Enteric Disease Testing and Therapeutic Market Drivers
11.3 Enteric Disease Testing and Therapeutic Market Challenges
11.4 Enteric Disease Testing and Therapeutic Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
